Maine Medicine Weekly Update - Maine Medicine Weekly Update: 12/24/2021  (Plain Text Version)

Return to Graphical Version

 

In this issue:
HAPPY HOLIDAYS FROM THE MMA
•  Enjoy The Holidays, Our Weekly Newsletter & Thank You For All You Do
COVID-19 CORNER
•  FDA Updates: Pfizer & Merck Oral Antivirals Authorized; Omicron & Monoclonal Antibodies
•  Maine CDC Updates & Guidance
•  Reminder: Everyone Ages 16 and Older Can Get a Booster Shot
•  US CDC Reduces Time for Health Care Workers to Isolate & Updates School Guidelines
•  English Study: Booster Shots Protect Against Omicron for About 10 Weeks
•  Patients Vaccinated for COVID-19 Have Shorter Hospital Stays Than Unvaccinated Patients
•  JAMA Internal Medicine - Illness Severity With SARS-CoV-2 Infection, Delta vs Beta Variant
•  US Supreme Court to Take Up Federal COVID-19 Vaccine Rules
WHAT'S NOT COVID RELATED
•  CDC: Physicians Should Discuss Meds to Reduce HIV Risk
•  HHS: $48 Million Available to Increase the Public Health Workforce in Rural and Tribal Communities
•  MaineCare: Payment Cycle Reminder: Christmas and New Year's Day Holidays
IN THE NEWS
•  Medicine in the Media
•  Walgreens Pharmacy Hours Change: Call Ahead Before Picking Up Your Medication
MAINE MEDICAL ASSOCIATION JOB OPPORTUNITY
•  Maine Medical Education Trust (MMET) CME Program Coordinator
HEALTH COVERAGE
•  Open Enrollment For 2022 Individual Health Plans
UPCOMING EVENTS
•  Upcoming Specialty Society Meetings
•  Governorís Opioid Response Seminar Webinar Series Continues (Jan 7)
HEALTHCARE EMPLOYMENT OPPORTUNITIES
•  Psychiatric Nurse Practitioner (PNP) - Greater Portland Health
•  Transformational OB/GYN or Maternal Fetal Medicine Physician leader

 

Maine CDC Updates & Guidance

The Maine CDC has transitioned to Pfizer’s gray cap formulation for adults and adolescents (gray cap) as of Friday, December 24.

The CDC has also shut off ordering the Johnson & Johnson COVID-19 vaccine through ImmPact.

The Maine CDC has transitioned to Pfizer’s gray cap formulation for adults and adolescents (gray cap) as of Friday, December 24.

The CDC has also shut off ordering the Johnson & Johnson COVID-19 vaccine through ImmPact.

They have closed for the 1170 dose Pfizer presentation (purple cap) and transitioning to the new presentation (gray cap) with a 300 minimum dose quantity.

Download the Maine CDC memo on Pfizer’s Gray Cap Formulation and Johnson & Johnson Updates

J&J COVID-19 Vaccine Updates

On Thursday, December 16, the U.S. CDC endorsed updated recommendations made by the Advisory Committee on Immunization Practices (ACIP) for the prevention of COVID-19,expressing a clinical preference for individuals to receive an mRNA COVID-19 vaccine overJohnson & Johnson.

To utilize current inventory levels across Maine, we will be shutting off ordering for the Johnson & Johnson COVID-19 vaccine in ImmPact. This change will be effective Friday,

December 24. For providers who choose to continue vaccinating with the Johnson & Johnson COVID-19 vaccine, an allocation request may be submitted to:

C19Allocations.MeCDC@maine.gov

Please contact the Maine Immunization Program with any questions at 207-287-3746 or

ImmunizeME.DHHS@maine.gov